Related Experiment Video
Updated: Aug 1, 2026
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Indeterminate cell histiocytosis treated successfully with 2-chlorodeoxyadenosine
M S Daoud1, P R Dahl, C H Dicken
1Department of Dermatology, Mayo Clinic Rochester, Minnesota 55905, USA.
Insights
A generalized papular eruption diagnosed as indeterminate cell histiocytosis showed improvement with 2-chlorodeoxyadenosine treatment. This finding offers a potential therapeutic option for this rare condition.
Area of Science:
- Dermatology
- Oncology
Background:
- Indeterminate cell histiocytosis (ICH) is a rare Langerhans cell-related disorder.
- Generalized papular eruption is a characteristic manifestation of ICH.
Observation:
- A 54-year-old male presented with a decade-long history of generalized papular eruption.
- The clinical presentation was consistent with indeterminate cell histiocytosis.
Findings:
- The patient received a course of 2-chlorodeoxyadenosine (2-CdA).
- Favorable response to 2-chlorodeoxyadenosine treatment was observed.
Implications:
- 2-chlorodeoxyadenosine demonstrates potential efficacy in managing indeterminate cell histiocytosis.
- This case highlights a viable treatment strategy for patients with generalized papular eruptions due to ICH.
Abstract:
We report the case of a 54-year-old man with a ten-year history of a generalized papular eruption consistent with the diagnosis of indeterminate cell histiocytosis. The patient responded favorably to a course of treatment with 2-chlorodeoxyadenosine.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016